These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Author: Tang S, Tang AW, Tam MK, Ho YW.
    Journal: Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073.
    Abstract:
    The authors report a case of adult-onset minimal change nephrotic syndrome (MCNS) that was resistant to steroid and cyclophosphamide therapy. Introduction of cyclosporin induced an usual cutaneous reaction of severe flushing attacks. Tacrolimus successfully alleviated both the nephrotic syndrome and the cutaneous side effect associated with cyclosporin use. The antiproteinuric mechanisms of tacrolimus and its potential in treating refractory MCNS and other forms of primary glomerulonephritides are discussed.
    [Abstract] [Full Text] [Related] [New Search]